课题基金 / 基金详情

Fundamental Study on objective diagnosis and therapy effect decision of the dementia by the molecular imaging.

Fundamental Study on objective diagnosis and therapy effect decision of the dementia by the molecular imaging.
分子影像对痴呆客观诊断及治疗效果判定的基础研究。
批准号:
13670925
负责人:
MORI Hirofumi
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003

项目摘要

项目成果

MORI Hirofumi的其他基金

相似基金

相关文献

中文摘要
翻译
帕金森病大鼠通过立体定向将6-OHDA注入单侧中脑纹状体多巴胺通路,并测量阿朴吗啡诱导的旋转行为。对照组注射生理盐水,而不是神经毒素。动物分为移植组(TP)和假手术组(S)。神经毒素注射2周后,手术切除同侧迷走神经结节,立体定向移植至同侧纹状体内。术后2周,连续行脑切片多巴胺能系统放射自显影。体外放射自显影测定多巴胺D_1、D_2受体和多巴胺转运体的密度。与对照组相比,模型组大鼠纹状体DAT显著降低(P<0.0001)。与假手术animals(S/R-,0.97±0.08;TP/R-,1.08±0.08;p=0.039…相比,移植动物同侧纹状体D_2受体显著增加More和S/R+1.06±0.06;TP/R+1.19±0.16;P=0.023),而DAT和D_1受体无明显变化。结果提示,迷走神经自体移植可诱导同侧纹状体D_2受体表达上调。自体移植对DAT没有显著影响,尽管DAT成像是多巴胺能损伤的敏感测试。我们对放射性碘标记的(-)-o-碘代氨基酚[(-)-OIV]作为一种选择性的囊泡性乙酰胆碱转运体(VAChT)标记剂的潜力进行了评价。(-)-[^<125>1]OIV在大鼠脑内显著蓄积。(-)-[125>1]OIV和[~3H]Vesamicol在脑内的放射性分布相似。未标记的维沙米考(0.5Mol/kg)和(-)-[OIVμμ/kg-1]可显著减少(-)-OIV在脑内的蓄积;而Sigma配体HARDY后给药则影响脑内(-)-OIV的积聚。这些研究表明,(-)-[^<125>1]OIV和[^~3H]维沙米考与Vacht在大鼠脑内具有很高的亲和力。[Funhemore,(-)-[^<125>1]OIV结合量在单侧NBM损毁大鼠同侧皮质与病变部位的结合比对侧皮质显著降低17.0%。这些结果表明,放射性碘(-)-[125>1]OIV可能对胆碱能神经退行性疾病的诊断有潜在的帮助。较少
英文摘要
Parkinsonian rats were stereotaxically infused 6-OHDA into the unilateral mesostriatal dopamine pathway and measured apomorphine-induced rotational behavior. Controls were infused saline instead of neurotoxin. Animals were divided into transplantation(TP) and sham-operated(S) groups. Ipsilateral vagal nodosal ganglion was surgically removed horn die neck and stereotaxically transplanted as nerve fragments into the ipsilateral striatum 2 weeks after nerotoxin infusion Sequential brain sections underwent autoradiography of dopaminergic system 2 weeks after operation. Densities of dopamine D1,D2 receptors and dopamine transporter(DAT) were assessed by in-vitro autoradiography using[^3H]SCH23390,[^3H]YM-09151-2 and[^3H]GBR12935. Significant DAT decrease in striatum was shown in the model animals compared with controls(P<0.0001). D_2 receptor in the ipsilateral striatum increased significantly in transplanted animals compared with sham-operated animals(S/R-,0.97±0.08;TP/R-,1.08±0.08;p=0.039 … More and S/R+,1.06±0.06;TP/R+,1.19±0.16;p=0.023), whereas DAT and D_1 receptor showed no significant changes. Our results suggest that vagal autotransplantation induces upregulation of D_2 receptor in the ipsilateral striatum. Autotransplantation showed no significant effect on DAT, although DAT imaging is a sensitive test for dopaminergic damage. We need hurther study on dopaminergic system imaging after neural transplantation.We evaluated the potencies of radioiodimted(-)-o-iodovesamicol [(-)-oIV] as a selective vesicular acetylcholine tmnsporter(VAChT) mapping agen. (-)-[^<125>1] oIV exhibited significant accumulationin rat brain. The regional brain distribution of radioactivity was similar for both (-)-[^<125>1] oIV and [^3H]vesamicol. The accumulation of (-)-[^<125>1] oIV in the brain was significant reduced by post-administration of unlabeled vesamicol(0.5μmol/kg^<-1>) and(-)-[^<125>1] oIV μmol/kg-1] in the other hand, the post-administration of sigma ligands hardy affected the accumulation of (-)-[^<125>1] oIV in die brain. These studies showed that (-)-[^<125>1] oIV, as well as [^3H]vesamicol, bound to VAChT with high affinity in die rat brain. Funhemore, (-)-[^<125>1] oIV binding in the ipsilateral cortex to the lesion was significantly reduced by 17.0%, compared with that in the contralateral cortex in a unilateral NBM-lesioned rat. These results suggested that radioiodimted(-)-[^<125>1] oIV may potentially be useful for the diagnosis of cholinergic neurodegenerative disorders. Less
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Shiba K.: "Chracterization of (-)radioisodinated (-)-ortho-iodovesamicol binding in rat brain preparations"Life Sciences. 71. 1591-1598 (2002)
Shiba K.:“大鼠脑制剂中 (-) 放射性碘化 (-)-邻碘维萨米考结合的表征”生命科学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shiba, K., Mori, H., Tonami, N.: "Evaluation of radioiodinated(-)-o-iodovesamicol as a radiotracer for mapping the vesicular acetylcholine transporter"Annals of Nuclear Medicine. 17・6. 451-456 (2003)
Shiba, K.、Mori, H.、Tonami, N.:“放射性碘化(-)-o-碘维沙考作为绘制囊泡乙酰胆碱转运蛋白的放射性示踪剂的评估”核医学年鉴 17・6(2003 年)。 )
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shiba, K, Mori, H., et al.: "Chracterization of (-)radioisodinated (-)-ortho-iodovesamicol binding in rat braid preparations"Life Sciences. 71. 1591-1598 (2002)
Shiba, K, Mori, H. 等人:“大鼠辫状制剂中 (-) 放射性碘化 (-)-邻碘维沙考结合的表征”生命科学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shiba, K, Mori, H., et al.: "Evaluation of radioiodinated(-)-o-iodovesamicol as a radiotracer for mapping the vesicular acetylcholine transporter"Annals of Nuclear Medicine. 17・6. 451-456 (2003)
Shiba, K, Mori, H., et al.:“放射性碘化(-)-o-碘维沙考作为绘制囊泡乙酰胆碱转运蛋白的放射性示踪剂的评估”《核医学年鉴》17・6(2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 6 条
    The effectiveness of the US Physical Education Teacher Education program from the point of view of the practical instruction skills
    • 批准号:
      24500715
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.58万
    • 财政年份:
      2012
    • 负责人:
      MORI Hirofumi
    • 依托单位:
    Development and evaluation of novel radiopharmaceuticals which are targeted to sigma receptors for comprehensive cancer therapy
    • 批准号:
      19591404
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2007
    • 负责人:
      MORI Hirofumi
    • 依托单位:
    Fundamental Study on Assessment of Neurotransplantation and Drug Treatment in Alzheimers Disease Using Nuclear Medicine Imaging
    • 批准号:
      10670832
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1998
    • 负责人:
      MORI Hirofumi
    • 依托单位:
    Fundamental Study on Assessment of Neurotransplantation Using Nuclear Medicine Imaging
    • 批准号:
      08671011
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.22万
    • 财政年份:
      1996
    • 负责人:
      MORI Hirofumi
    • 依托单位:
    国内基金
    海外基金
    Succinate-Succinate Receptor介导的代谢反应在正畸牙根吸收中的作用
    • 批准号:
      82371007
    • 项目类别:
      面上项目
    • 资助金额:
      48万元
    • 批准年份:
      2023
    • 负责人:
      雷浪
    • 依托单位:
    Leptin receptor阳性细胞通过分泌Hedgehog蛋白调控椎间盘退变及修复的谱系研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      傅强
    • 依托单位:
    丹参酮ⅡA通过靶向TRAIL-receptor和ULBPs增强NK细胞抗非小细胞肺癌效应的作用及分子机制研究
    • 批准号:
      81903932
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2019
    • 负责人:
      龚陈媛
    • 依托单位:
    白介素-1受体相关激酶(Interleukin-1 receptor associated kinase,IRAK)-M调节哮喘气道炎症异质性和气道重塑以及相关机制的研究